Roles of Salmonella multidrug efflux pumps in tigecycline resistance

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 1, 2011, Pages 105-110

  Horiyama, Tsukasa ^a   Nikaido, Eiji ^a   Yamaguchi, Akihito ^a   Nishino, Kunihiko ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Glycylcyclines; Multidrug resistance; Resistance nodulation cell division family

Indexed keywords

9 (N,N DIMETHYLGLYCYLAMIDO) 6 DEMETHYL 6 DEOXYTETRACYCLINE; DOXYCYCLINE; GLYCYLCYCLINE DERIVATIVE; MEMBRANE PROTEIN; MINOCYCLINE; MULTIDRUG EFFLUX PUMP ACRAB; MULTIDRUG EFFLUX PUMP ACREF; REGULATOR PROTEIN; REGULATOR PROTEIN RAMA; REGULATOR PROTEIN RAMR; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; GENE; GENE DELETION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; SALMONELLA ENTERICA; TET GENE;

BACTERIAL PROTEINS; CARRIER PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE DELETION; GENE EXPRESSION; GENES, MDR; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PLASMIDS; SALMONELLA TYPHIMURIUM;

EID: 78650314989     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq421     Document Type: Article

References (37)

1. Scherer CA, Miller SI. Molecular pathogenesis of Salmonella. In: Groisman EA, ed. Principles of Bacterial Pathogenesis. New York: Academic Press, 2001; 266-333.
2. Glynn MK, Bopp C, Dewitt W et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998; 338: 1333-8.
3. Threlfall EJ, Ward LR, Skinner JA et al. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist 1997; 3: 263-6.
4. Ng LK, Mulvey MR, Martin I et al. Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob Agents Chemother 1999; 43: 3018-21.
5. Hosek G, Leschinsky DD, Irons S et al. Multidrug-resistant Salmonella serotype Typhimurium-United States, 1996. Morb Mortal Wkly Rep 1997; 46: 308-10.
6. Cody SH, Abbott SL, Marfin AA et al. Two outbreaks of multidrug-resistant Salmonella serotype Typhimurium DT104 infections linked to raw-milk cheese in northern California. JAMA 1999; 281: 1805-10.
7. Davies A, O'Neill P, Towers L et al. An outbreak of Salmonella typhimurium DT104 food poisoning associated with eating beef. Commun Dis Rep CDR Rev 1996; 6: R159-62.
8. Grein T, O'Flanagan D, McCarthy T et al. An outbreak of multidrug-resistant Salmonella typhimurium food poisoning at a wedding reception. Ir Med J 1999; 92: 238-41.
9. Molbak K, Baggesen DL, Aarestrup FM et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med 1999; 341: 1420-5.
10. Villar RG, Macek MD, Simons S et al. Investigation of multidrugresistant Salmonella serotype Typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA 1999; 281: 1811-6.
11. Cloeckaert A, Chaslus-Dancla E. Mechanisms of quinolone resistance in Salmonella. Vet Res 2001; 32: 291-300.
12. Piddock LJ. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 2002; 26: 3-16.
13. Nikaido H. Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 1996; 178: 5853-9.
14. Zgurskaya HI, Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol 2000; 37: 219-25.
15. Petersen PJ, Jacobus NV, Weiss WJ et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 1999; 43: 738-44.
16. Peterson LR. A review of tigecycline-the first glycylcycline. Int J Antimicrob Agents 2008; 32 Suppl 4: S215-22.
17. Kelesidis T, Karageorgopoulos DE, Kelesidis I et al. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 2008; 62: 895-904.
18. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis 2006; 43: 518-24.
19. Dean CR, Visalli MA, Projan SJ et al. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 2003; 47: 972-8.
20. Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist 2007; 13: 1-6.
21. Keeney D, Ruzin A, McAleese F et al. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. J Antimicrob Chemother 2008; 61: 46-53.
22. Ruzin A, Keeney D, Bradford PA. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother 2005; 49: 791-3.
23. Hentschke M, Wolters M, Sobottka I et al. ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline. Antimicrob Agents Chemother 2010; 54: 2720-3.
24. Capoor MR, Nair D, Posti J et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58: 337-41.
25. Nishino K, Latifi T, Groisman EA. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 2006; 59: 126-41.
26. Nishino K, Nikaido E, Yamaguchi A. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim Biophys Acta 2009; 1794: 834-43.
27. Nikaido E, Yamaguchi A, Nishino K. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 2008; 283: 24245-53.
28. Abouzeed YM, Baucheron S, Cloeckaert A. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008; 52: 2428-34.
29. Fields PI, Swanson RV, Haidaris CG et al. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc Natl Acad Sci USA 1986; 83: 5189-93.
30. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
31. Nishino K, Yamada J, Hirakawa H et al. Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to β-lactams. Antimicrob Agents Chemother 2003; 47: 3030-3.
32. Fluit AC, Florijn A, Verhoef J et al. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother 2005; 49: 1636-8.
33. Hirata T, Saito A, Nishino K et al. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob Agents Chemother 2004; 48: 2179-84.
34. McNicholas P, Chopra I, Rothstein DM. Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol 1992; 174: 7926-33.
35. Tuckman M, Petersen PJ, Projan SJ. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines. Microb Drug Resist 2000; 6: 277-82.
36. Nishino K, Hayashi-Nishino M, Yamaguchi A. H-NS modulates multidrug resistance of Salmonella enterica serovar Typhimurium by repressing multidrug efflux genes acrEF. Antimicrob Agents Chemother 2009; 53: 3541-3.
37. Horiyama T, Yamaguchi A, Nishino K. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2010; 65: 1372-6.